Home
About
Overview
Sharing Data
ORCID
Help
History (5)
An Approach for Assessing Turbulent Flow Damage to Blood in Medical Devices.
Cellular interactions and biomechanical properties of a unique vascular-derived scaffold for periodontal tissue regeneration.
Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.
Factors associated with transitions in tobacco product use states among young adults aged 18-29 years.
PRMT5 is a therapeutic target in choroidal neovascularization.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PRMT5 is a therapeutic target in choroidal neovascularization.
PRMT5 is a therapeutic target in choroidal neovascularization. Sci Rep. 2023 01 31; 13(1):1747.
View in:
PubMed
subject areas
Animals
Choroidal Neovascularization
Endothelial Cells
Humans
Mice
NF-kappa B
Pancreatic Neoplasms
Protein-Arginine N-Methyltransferases
Retina
Vascular Endothelial Growth Factor A
authors with profiles
Nathan Robert Jensen